Depakine 200 mg - Sanofi (Valproate de Sodium Capsule) 200mg

Depakine 200 mg capsules contain valproate de sodium, a medication used for seizure control and mood stabilization. Suitable for ambient storage, these 200mg capsules offer a convenient 40-count pack. Explore valproate de sodium capsules for epilepsy and bipolar disorder support.

Strength

200mg

Pack Size

40s

Storage

Ambient

Manufacturer / TM Owner

SANOFI

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Valproate de sodium, the active ingredient in Depakine 200 mg capsules, is commonly used to help manage seizures and epilepsy. It is also prescribed for mood stabilization in bipolar disorder. Patients and caregivers often ask, 'what is valproate de sodium used for' to understand its role in neurological and psychiatric conditions.

Side Effects

Valproate de sodium capsules may help reduce the frequency and severity of seizures in epilepsy. For mood stabilization, they can contribute to balancing mood fluctuations associated with bipolar disorder. Users may notice improved stability in daily functioning over time.

Precautions & Warnings

Store Depakine 200 mg capsules at room temperature, away from moisture and direct sunlight. Keep the medication in its original packaging until ready to use. Always check the expiration date before taking. If you have concerns about storage or handling, consult your pharmacist.

Avoid Interactions

Valproate de sodium may interact with other medications, including certain antidepressants, antipsychotics, and blood thinners. Alcohol and grapefruit juice can also affect how the medication works. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Valproate de sodium is primarily used to control seizures in epilepsy and to stabilize mood in bipolar disorder.

Store the capsules at room temperature, away from moisture and heat, in their original packaging.

Alcohol may interact with valproate de sodium; consult your healthcare provider before consuming alcohol.

If you miss a dose, take it as soon as you remember. If it is almost time for the next dose, skip the missed one and continue with your regular schedule.

Common side effects may include nausea, dizziness, or drowsiness. Report persistent or severe effects to your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.